The Victorian Comprehensive Cancer Centre Alliance, or VCCC Alliance for short, is a Victorian partnership of 10 research, academic and clinical institutions looking at improving cancer outcomes for patients:
- Peter MacCallum Cancer Centre
- The Royal Melbourne Hospital
- University of Melbourne
- The Royal Women’s Hospital
- WEHI
- The Royal Children’s Hospital
- Western Health
- St Vincent’s Hospital Melbourne and St Vincent’s Institute
- Austin Health and Olivia Newton-John Cancer Research Institute
- Murdoch Children’s Research Institute
The VCCC Alliance SKILLED clinical trial internships program is a pathway for scientists to build role-specific clinical trial knowledge, experience and in a clinical trials unit through theoretical and on-the-job training. The internship program is a 40 week intensive program to get science student interns job ready for clinical trial assistant and study coordinator internship roles.
The program is funded in part by MTPConnect’s $32 million REDI initiative, supported by the Medical Research Future Fund. Now into it’s 4th year, VCCC Alliance’s SKILLED Clinical Trials Internship program commenced in 2019 and by year end 2022 would have placed 77 interns into clinical trial units.
Australian Health Journal spoke with Chris Packer, Manager, SKILLED Clinical Trials Internship program at the VCCC Alliance about the need to build capacity of clinical trial units, especially with reductions on overseas travellers in the sector and other factors leading to gaps in the workforce.
In 2022, 22 intern have been placed in large tertiary facilities as well as in regional Victoria.
Australian Health Journal spoke with 2 recent interns about their experiences during and following the internship program:
- Dulash Fernando, Clinical Trials Assistant
- Rebecca Komesaroff, VCCC Skilled Intern (CTA)
Australian Health Journal also spoke to some of the host sites about the program and the important need to fill the clinical trial skills gap.
- Dr Sarah Rickard, Director Research Governance and Ethics, The Royal Melbourne Hospital
- Kate Scarff, Clinical Research Development Office Lead, Melbourne Children’s Trials Centre, Murdoch Children’s Research Institute
- Narelle McPhee, Cancer Research Manager, Bendigo Health
Narelle talks about the importance and uniqueness of the internship program for the staff in the Bendigo region. She sees the program as a strong partnership with VCCC Alliance, the intern and the clinical trials unit in Bendigo Health, that helps with future recruitment as well bringing new perspectives. There are opportunities in regional and rural locations undertaking clinical trials, and Narelle happily states, the interns they have previously hosted have gained employment in the region.
Internship evaluations by interns and the host sites in 2021 Net Promotor Scores (NPS) have shown high levels of satisfaction levels both from interns and host sites in the program. As further testament to its success, 95% of interns have gone back into the clinical trial sector since the commencement of the program.
Produced with assistance from:
ARCS Australia
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
Clinical trial site in primary care setting open for novel therapies in psychiatry
Over the past decade, Paratus has been involved in over 200 clinical trials across 4 clinical site locations. Now a fifth site, the newly opened Melbourne site will cater to both primary care and psychiatry, specifically designed for psychedelic studies.
The new Melbourne site will be a focused on primary care studies specifically expanding access to psychiatric research, a growing area of unmet need. Australian Health Journal met with 3 recent hires brought in to support clinical trials across the organisation and in psychiatry in Melbourne.
-
Keeping elderly out of hospital
Pioneer in health care, Geriatrician Professor Susan Kurrle, Curran Professor in Health Care of Older People at the Faculty of Medicine and Health, University of Sydney AO spoke after receiving the Australian Healthcare and Hospitals Association 2022 Sidney Sax medal award.
The Sidney Sax medal is awarded for outstanding contributions to the development and improvement of Australia’s healthcare system.
